Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Oxymetholone MeSH Descriptor Data 2026


MeSH Heading
Oxymetholone
Tree Number(s)
D04.210.500.054.040.632
Unique ID
D010110
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D010110
Scope Note
A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed)
Entry Term(s)
Anadrol
Anapolon 50
Hydroxymetholone
Oxymethalone
Oxymetholone, (17 beta)-Isomer
Oxymetholone, (5 alpha,17 alpha)-Isomer
Pharm Action
Androgens
Anabolic Agents
Registry Numbers
L76T0ZCA8K
138231-84-2
18045-52-8
0
Related Numbers
138231-84-2
18045-52-8
434-07-1
CAS Type 1 Name
Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5alpha,17beta)-
Public MeSH Note
65
History Note
65
Date Introduced
1965/01/01
Last Updated
2016/05/31
Oxymetholone Preferred
Oxymetholone, (5 alpha,17 alpha)-Isomer Narrower
Oxymetholone, (17 beta)-Isomer Narrower
Anadrol Narrower
Anapolon 50 Narrower
page delivered in 0.142s